SAN ANTONIO, Texas, Feb. 28, 2018 /PRNewswire/ -- CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced the upcoming educational events to take place…
News
- COBRA PzF NanoCoated Coronary Stent (NCS) to be Highlighted at CRT 2018 Meeting
- A marijuana startup is listing on a major US stock exchange for the first time — here's what you ...
Cronos Group will become the first marijuana company to trade on a major US stock exchange. The company owns and operates businesses that are licensed to grow and sell weed in Canada, where medical marijuana is legal. The listing could signal to governments and investors that the legal…
- A fertility doctor's secret, a special kinship decades later
She took a DNA test from 23andMe, a biotech company that uses saliva samples to determine ancestry and identify distant and close relatives, health risks and physical traits. Ballard's results listed seven half-siblings. She and two others assembled a family tree and realized their mothers had…
- Investigative Ebola Treatment ZMapp to Undergo Testing
ZMapp, the monoclonal antibody combination therapy that was used to treat humans during the 2014 West Africa Ebola outbreak before even reaching human clinical trials, will be further researched by the Texas Biomedical Research Institute in San Antonio. The institute was granted a $2 million…
- Scott's Take: SA may have found a path to more research funding
San Antonio health care and bioscience organizations have embraced local collaboration in a way that has set the city apart from other markets. But if the trend in CPRIT funding is an indication, the Alamo City may need to explore a wider geographic approach to cooperative pursuits and…